Chicago · 100% Virtual

Prescription · Requires Consultation

Weight loss in Chicago, without losing the engine.

Written by the Elevate Clinical Team

Citations independently verified against PubMed, ClinicalTrials.gov, and FDA sources on . Independent clinical review pending.

Elevate Chicago is a physician-led metabolic and hormone practice serving patients nationwide entirely by telehealth. Single- and dual-regulator GLP-1 protocols are written by the physician who read your labs — and built so what you lose is fat, not muscle.

Who this is for

  • Patients who want meaningful fat loss without losing performance.
  • Anyone with insulin resistance or metabolic syndrome markers.
  • People who have plateaued on diet and training alone.
  • Patients coming off a GLP-1 who want to hold the result.

Why most GLP-1 programs cost you muscle

GLP-1 medications work — and used without a plan they take muscle, strength and metabolic rate with the fat. A prescription mailed out after a two-minute questionnaire is not a protocol. Our metabolic protocols pair medication with protein targets, resistance training guidance and, where indicated, muscle-sparing peptides, so the number on the scale means something.

What your program includes

  • Metabolic and insulin-resistance biomarker panel inside a 65-biomarker draw.
  • GLP-1 or dual-agonist therapy titrated by a physician.
  • Muscle-preservation strategy: protein, training and adjunct support.
  • Body composition tracking, not just scale weight.
  • Off-ramp planning so results hold after the medication.

Medications we work with

  • Single Regulator (GLP-1) — semaglutide. Compounded formulations cannot be marketed under the drug's commercial name; the active ingredient is the same one found in FDA-approved products, but compounded formulations are not themselves FDA-approved.
  • Dual Regulator (GLP-1/GIP) — tirzepatide. Compounded formulations cannot be marketed under the drug's commercial name; the active ingredient is the same one found in FDA-approved products, but compounded formulations are not themselves FDA-approved.
  • Tesamorelin — FDA-approved, studied in visceral adipose tissue signaling.
  • Muscle-sparing and metabolic adjuncts such as CJC-1295 + Ipamorelin, reviewed case by case.

Hormones decide how well weight loss works

Low testosterone, an under-treated thyroid, high cortisol or poor sleep will blunt any weight loss protocol and accelerate muscle loss during a calorie deficit. That is why the panel comes before the prescription. See hormone therapy in Chicago for that side of the work.

What the process looks like

  • 01 — Apply and book. A $100 application fee reserves your intake and is credited toward your first order.
  • 02 — Baseline labs. A 65-biomarker panel drawn at a Quest location near you — the Loop, Lincoln Park, Evanston, Naperville or Oak Brook.
  • 03 — Physician video visit. Thirty minutes on every value, your training and your goals.
  • 04 — Your protocol. Physician-designed, shipped to your door, with dosing and coaching built in.
  • 05 — Ongoing optimization. Repeat Quest labs and continual titration as your biology changes.

Medications and sourcing

Prescribed therapies are dispensed through FDA-registered compounding pharmacies and licensed pharmacy partners when available. Research-use compounds, where offered, are a separate category — not FDA-approved, not prescribed as medical care, and not intended for human or animal consumption.

Frequently asked questions.

How much weight do people actually lose on GLP-1 therapy?
Published trials of semaglutide (single-regulator GLP-1) and tirzepatide (dual-regulator GLP-1/GIP) report average total body weight reductions in the mid-teens to low twenties percent over roughly a year and a half, on top of diet and activity change. Individual results vary widely, and the average is not a promise.
How do you keep me from losing muscle?
That is the reason for the lab panel and the protein-and-resistance-training requirement. Dose escalation is deliberately slower than the package titration when body composition is the goal, and follow-up labs track markers that move when lean mass is being burned instead of fat.
What happens when I stop the medication?
Appetite signaling returns and weight regain is common when nothing else has changed. The program is built around an exit: strength, protein intake and metabolic markers are worked on during therapy so that a maintenance dose or a taper is a real option rather than a cliff.
What are the side effects?
Nausea, constipation, reflux and early satiety are the common ones and are largely dose-dependent. Rarer but serious concerns — pancreatitis, gallbladder disease, and a contraindication in medullary thyroid carcinoma or MEN2 — are screened for before you are prescribed anything.
Do I need to be diabetic to qualify?
No. Eligibility is assessed on your full metabolic picture — BMI, waist, fasting insulin, HbA1c, lipids and hormone status — not on a diabetes diagnosis. Some people who ask about GLP-1s turn out to have a thyroid or hormone problem driving the weight instead, which is why the panel comes first.

Sources

  1. 1.Prescription medications to treat overweight and obesityNational Institute of Diabetes and Digestive and Kidney Diseases, NIH
  2. 2.Medications containing semaglutide marketed for type 2 diabetes or weight lossU.S. Food & Drug Administration
  3. 3.FDA-approved prescribing information for semaglutideDailyMed, U.S. National Library of Medicine
  4. 4.FDA-approved prescribing information for tirzepatideDailyMed, U.S. National Library of Medicine
  5. 5.Test directory and patient service center locatorQuest Diagnostics

About this page

Written by the Elevate Clinical Team

Citations independently verified against PubMed, ClinicalTrials.gov, and FDA sources on . Independent clinical review pending. Educational content only — not medical advice, not a diagnosis, and not an offer to sell any prescription product.

Next step

Find out what your numbers actually say.

A $100 application fee reserves your intake and is credited toward your first order. 65 biomarkers at Quest, then thirty minutes with your physician.